Osce Topics Flashcards
Antenatal screening components
- Infections
- Maternal
- Genetics
Antenatal screening components
- Infections
1. BBVs
2. Syphilis
3. Asymptomatic bacturia - Maternal
1. Blood
2. PET risk
3. Psychiatry - Genetics
1. Downs
2. Anomalies
3. Neural tube
Ultrasound in pregnancy
- Calls
- NT
- Bowel
Ultrasound in pregnancy
- Calls
1. 11-13 - NT
1. Down’s
2. Heart
3. Abdominal wall - Bowel
1. CF
2. Down’s
3. CMV
SGA
- Definition
- Causes
- Mx
SGA
- Definition
1. <10th centile
2. Severe <3rd
- Causes
1. Constitutional (50-70%)
2. Placenta FGR (low BMI, substances, AI condition, renal, DM, HTN)
3. Non placenta FGR (chromosome, structure, metabolic, infection) - Mx
1. USS (AC and HC) - Fetal anatomical survey
2. UAD. (Uterine A. Doppler)
3. Karyotyping and infection screens
- Steroids
- Induction/C Section
Abnormal lie, position, presentation
- identification
- Mx and risks
Abnormal lie, proportion, presentation
- identification
1. Palpation
2. VE during labour - Mx
1. USS
- ECV
- 50-60%
- Fetal distress, PROM, APH, Rupture
- No recent APH, RoM, previous section, abnormalities
PROM and PPRoM
- Definitions
- Ix
- Mx
- Risks
PROM and PPRoM
- Definitions
1. PROM - At least 1 hour prior to labour - 15% of term
2. PPROM - Prior to 37 weeks - 2% pregnancies and 40% preterm
3. Chorion and amnion weakened - Enzymes, Infections, Genetics
- Ix
1. Amnisure (PaMg1)
2. Actim-Prom (IGF BP 1)
3. HVS (GBS) - Mx
1. 36+ - Induce
2. 34 - steroids +/- Induce
3. 34 - favour gestation - Risks
1. Infection (chorioamnionitis)
2. Oligohydramnios (lungs)
3. Cord prolapse
4. Abruption
5. Neonatal death (prem, sepsis, lungs)
VBAC
- Risks (2)
- Benefits (4)
- Mx (5)
VBAC
- Risks
1. Uterine rupture (0.5%)
2. Anal sphincter injury (5%) - Benefits
1. Shorter stay
2. Lower maternal risk
3. Increased future VBAC
4. Lower transient tachypnoea - Mx
1. Hospital setting
2. Continuous CTG
3. Mechanical induction (not prostaglandins)
4. Senior input
5. Only prior to 39 weeks
Multiple pregnancy
- Incidence
- ANC
- Birth mx
Multiple pregnancy
- Incidence
1. 1/60
2. Older mothers, fertility treatment - ANC
1. Consultant lead
2. Care plan
3. Additional visits and growth scans
4. Fetal medicine input - Birth
1. VD (usually induced) - 1/3 end up CS
2. CS - Monoamniotic or 3+
3. Cannula and epidural
4. Timing - 37 DCDA
- 36 MCDA
- 35 triplet
- 34 MCMA
Gestational diabetes
- Incidence
- Risks
- Ix
- Mx
Gestational diabetes
- Incidence
1. 1/5 - Risks
1. Macrosomia - dystocia, delayed labour, instrumental delivery
2. Organomegaly - cardiomegaly
3. Polycythaemia
4. Polyhydramnios
5. Prematurity - Ix
1. OGTT (5678)
2. 2+ glucosuria (1+ x2) - Mx
0. Consultant led, GS at 28,32,36
1. Lifestyle
- Metformin
- Glibenclamide (SU)
- Insulin
- Deliver at 37-38
- PP fasting glucose 6-13 weeks
- OGTT subsequent pregnancies
GBS colonisation
- Incidence
- Mx
GBS colonisation
- Incidence
1. 25% of pregnant women
2. 0.05% of neonates (5% mortality) - Mx
1. High dose IV pen - Benpen
( - Cefuroxime
- Clindamycin)
Hyperemesis Gravidarum
- Incidence and timing
- Ix
- Mx
Hyperemesis Gravidarum (HG)
- Incidence
1. 3% of women
2. Starts 4-7 weeks peaking 9th
3. Settles by 20 in 90% - Ix
1. Weight
2. Urine dip and CBG
3. FBC, U&Es, LFTs
4. TFTs
5. ABG - Mx
1. Mild - Hydration, diet, oral antiemetics
- Moderate
- Ambulatory care
- IV fluids, IV antiemetics, Pabrinex - Severe
- IV hydration
- Cyclizine (H1)
- Prochlorperazine (D2), promethazine (H1), chlorpromazine (H1, D2, M1)
PET
- Incidence
- Complications
- Ix
- Mx
PET
- Incidence
1. 5% - Complications
1. HELLP
2. Eclampsia
3. AKI
4. DIC, ARDS, CVA, Death - Ix
0. BP
1. Urine dip, 24hr urine
2. FBC
3. U&E, LFT - Mx
1. Labetalol - not asthma, HpoT, N&V
2. Nifedipine - oedema, flushing, dizzy, constipated
3. Methyldopa - Drowsy, headache, GI, oedema, brady
Epilepsy in pregnancy
- Risks
- Mx
Epilepsy in pregnancy
- Risks
1. Small but significant increase in obstetric risk
2. Haemorrhagic disease of the newborn (Vit K deficiency) - Mx
1. 5mg/day folate
2. Lowest possible AED dose (not valproate)
3. Good sleep and reduced stress
4. Growth scans for SGA
5. 1mg IM vitamin K
6. Consider long acting benzo if high risk for peripartum seizure
Asthma in pregnancy
- Incidence
- Mx
Asthma in pregnancy
- Incidence
1. 10% of pregnant women
2. 1/3 worsening control - Mx
1. No risks of inhaled CSTs or LABA
2. Theophylline safe in pregnancy
3. Continuous CTG in acute exacerbation
4. Caution with Ergometrine, oxytocin, and Prostaglandin
Obstetric cholestasis
- Incidence
- Risks
- Ix
- Mx
Obstetric cholestasis
- Incidence
1. 1%
2. South Asian higher - Risks
1. Raised PET
2. Raised GDM
3. Stillbirth if 100micromol/L - Ix
1. LFTs (ALT)
2. Random total bile acid (19micromol/L) - Repeat at 1 week
3. LFTs after birth - Mx
1. Topical emollients
2. Chlorphenamine
(3. Ursodeoxycholic acid)
4. 38-39 weeks induction
5. 35 wk induction if 100 micromol/L
VTE in Pregnancy
- Prevalence
- Prevention
- Mx
VTE in Pregnancy
- Prevalence
1. 1/3 maternal deaths
2. 4-5x increased risk
3. Highest risk postpartum - Prevention
0. 4RFs inT1-2, 3 rfs in T3, 2rfs pp
1. LMWH (Clexane) - Mx
0. Bloods and coag
1. Duplex USS
2. LMWH until 6-12wk pp
3. UFH used at term